Total Payments
$4,185
2022 Payments
$53.75
Companies
10
Transactions
32
Medicare Patients
8,417
Medicare Billing
$407,393
Payment Breakdown by Category
Consulting$2,350 (56.2%)
Food & Beverage$1,798 (43.0%)
Education$21.70 (0.5%)
Travel$15.00 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,350 | 1 | 56.2% |
| Food and Beverage | $1,798 | 29 | 43.0% |
| Education | $21.70 | 1 | 0.5% |
| Travel and Lodging | $15.00 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,465 | 3 | $0 (2020) |
| PFIZER INC. | $451.91 | 13 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $399.97 | 4 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $281.63 | 3 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $270.51 | 3 | $0 (2019) |
| Boston Scientific Corporation | $123.02 | 2 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $115.37 | 1 | $0 (2019) |
| Lantheus Medical Imaging, Inc. | $30.91 | 1 | $0 (2021) |
| Abbott Laboratories | $24.84 | 1 | $0 (2018) |
| Merck Sharp & Dohme LLC | $21.70 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $53.75 | 3 | PFIZER INC. ($32.05) |
| 2021 | $45.60 | 2 | Lantheus Medical Imaging, Inc. ($30.91) |
| 2020 | $2,379 | 3 | Novartis Pharmaceuticals Corporation ($2,365) |
| 2019 | $842.12 | 13 | PFIZER INC. ($292.64) |
| 2018 | $504.62 | 6 | Janssen Pharmaceuticals, Inc ($323.77) |
| 2017 | $359.56 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($170.67) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/06/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Education | In-kind items and services | $21.70 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/06/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/01/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/29/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/19/2021 | Lantheus Medical Imaging, Inc. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $30.91 | General |
| Category: CONTRAST AGENT | ||||||
| 07/09/2020 | Novartis Pharmaceuticals Corporation | TABRECTA (Drug) | Consulting Fee | Cash or cash equivalent | $2,350.00 | General |
| Category: ONCOLOGY | ||||||
| 02/05/2020 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | Cash or cash equivalent | $15.00 | General |
| 01/27/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/11/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $99.84 | General |
| Category: DIABETES | ||||||
| 10/22/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $42.33 | General |
| Category: STRUCTURAL HEART | ||||||
| 08/14/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $118.98 | General |
| Category: Cardiovascular | ||||||
| 08/05/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/25/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/19/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $44.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/07/2019 | Regeneron Healthcare Solutions, Inc. | PRALUENT (Biological) | Food and Beverage | In-kind items and services | $115.37 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 03/26/2019 | Boston Scientific Corporation | GENERAL THERAPIES (Device) | Food and Beverage | In-kind items and services | $80.69 | General |
| Category: THERAPIES | ||||||
| 02/06/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $92.27 | General |
| Category: Cardiovascular | ||||||
| 02/05/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $110.30 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/23/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $3.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/12/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $87.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/04/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $118.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/17/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $70.38 | General |
| Category: Cardiovascular | ||||||
| 09/06/2018 | Abbott Laboratories | HeartMate 3 Left Ventricular Dev (Device) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,056 | 2,542 | $278,588 | $94,934 |
| 2022 | 20 | 2,004 | 2,519 | $294,257 | $97,800 |
| 2021 | 26 | 2,205 | 2,737 | $317,559 | $109,143 |
| 2020 | 23 | 2,152 | 2,598 | $309,549 | $105,516 |
Total Patients
8,417
Total Services
10,396
Medicare Billing
$407,393
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 347 | 482 | $89,137 | $29,108 | 32.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 148 | 197 | $51,404 | $17,324 | 33.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 144 | 146 | $22,190 | $7,263 | 32.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 50 | 51 | $14,008 | $5,124 | 36.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 30 | 30 | $10,494 | $3,884 | 37.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 357 | 403 | $11,863 | $3,861 | 32.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 40 | 63 | $10,144 | $3,839 | 37.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 72 | 72 | $11,103 | $3,765 | 33.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $9,538 | $3,467 | 36.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 60 | 60 | $9,534 | $3,303 | 34.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 359 | 503 | $8,108 | $2,937 | 36.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 33 | 51 | $5,085 | $1,857 | 36.5% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 102 | 103 | $4,371 | $1,581 | 36.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 36 | 52 | $3,883 | $1,327 | 34.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 14 | $3,216 | $1,041 | 32.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 101 | 102 | $2,886 | $1,040 | 36.0% |
| 93284 | Programming of multiple lead implantable defibrillator system | Office | 2023 | 13 | 19 | $2,323 | $834.66 | 35.9% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 11 | 11 | $2,205 | $817.29 | 37.1% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 11 | 39 | $2,048 | $734.44 | 35.9% |
| 93279 | Programming of single lead pacemaker system | Office | 2023 | 14 | 22 | $1,388 | $524.26 | 37.8% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 24 | 25 | $1,320 | $491.75 | 37.3% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 18 | 19 | $905.00 | $321.48 | 35.5% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 11 | 14 | $594.00 | $192.48 | 32.4% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 12 | 12 | $447.00 | $151.10 | 33.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 22 | 24 | $394.00 | $143.64 | 36.5% |
About Dr. David Broza, MD
Dr. David Broza, MD is a Cardiovascular Disease healthcare provider based in East Greenwich, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083652408.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Broza, MD has received a total of $4,185 in payments from pharmaceutical and medical device companies, with $53.75 received in 2022. These payments were reported across 32 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($2,350).
As a Medicare-enrolled provider, Broza has provided services to 8,417 Medicare beneficiaries, totaling 10,396 services with total Medicare billing of $407,393. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location East Greenwich, RI
- Active Since 06/04/2006
- Last Updated 12/08/2023
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1083652408
Products in Payments
- TABRECTA (Drug) $2,350
- ELIQUIS (Drug) $596.07
- XARELTO (Drug) $399.97
- JARDIANCE (Drug) $270.51
- VYNDAQEL (Drug) $125.00
- PRALUENT (Biological) $115.37
- ENTRESTO (Drug) $100.22
- GENERAL THERAPIES (Device) $80.69
- WATCHMAN (Device) $42.33
- DEFINITY (Drug) $30.91
- HeartMate 3 Left Ventricular Dev (Device) $24.84
- VERQUVO (Drug) $21.70
- CHANTIX (Drug) $12.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in East Greenwich
Dr. Karen Aspry, Md, MD
Cardiovascular Disease — Payments: $412.20
Cardiovascular Disease $412.20
Lincoln Tirpaeck, Do, DO
Cardiovascular Disease — Payments: $356.73
Cardiovascular Disease $356.73
Joseph Wyllie, Do, DO
Cardiovascular Disease — Payments: $95.12
Cardiovascular Disease $95.12
Mr. Brian Abbott, Md, MD
Cardiovascular Disease — Payments: $16.37
Cardiovascular Disease $16.37